JP2006501245A5 - - Google Patents

Download PDF

Info

Publication number
JP2006501245A5
JP2006501245A5 JP2004531589A JP2004531589A JP2006501245A5 JP 2006501245 A5 JP2006501245 A5 JP 2006501245A5 JP 2004531589 A JP2004531589 A JP 2004531589A JP 2004531589 A JP2004531589 A JP 2004531589A JP 2006501245 A5 JP2006501245 A5 JP 2006501245A5
Authority
JP
Japan
Prior art keywords
alkyl
halogen
hydrogen
alkoxy
hydroxyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2004531589A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006501245A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/026886 external-priority patent/WO2004019874A2/en
Publication of JP2006501245A publication Critical patent/JP2006501245A/ja
Publication of JP2006501245A5 publication Critical patent/JP2006501245A5/ja
Withdrawn legal-status Critical Current

Links

JP2004531589A 2002-08-30 2003-08-27 置換された5−クロマン−5−イル−エチルアミン化合物および緑内障の治療のためのその使用 Withdrawn JP2006501245A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40721002P 2002-08-30 2002-08-30
PCT/US2003/026886 WO2004019874A2 (en) 2002-08-30 2003-08-27 Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma

Publications (2)

Publication Number Publication Date
JP2006501245A JP2006501245A (ja) 2006-01-12
JP2006501245A5 true JP2006501245A5 (https=) 2006-06-15

Family

ID=31978438

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004531589A Withdrawn JP2006501245A (ja) 2002-08-30 2003-08-27 置換された5−クロマン−5−イル−エチルアミン化合物および緑内障の治療のためのその使用

Country Status (13)

Country Link
US (1) US20050171190A1 (https=)
EP (1) EP1545501A2 (https=)
JP (1) JP2006501245A (https=)
KR (1) KR20050033654A (https=)
CN (1) CN1678302A (https=)
AR (1) AR041080A1 (https=)
AU (1) AU2003262931B2 (https=)
BR (1) BR0314419A (https=)
CA (1) CA2495192A1 (https=)
MX (1) MXPA05002259A (https=)
PL (1) PL375564A1 (https=)
WO (1) WO2004019874A2 (https=)
ZA (1) ZA200501288B (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6960579B1 (en) 1998-05-19 2005-11-01 Alcon Manufacturing, Ltd. Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders
TW593302B (en) 2001-12-20 2004-06-21 Alcon Inc Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma
BR0316775A (pt) 2002-12-13 2005-11-01 Alcon Inc Novos análogos de benzopirano e seu uso para o tratamento de glaucoma
US7476687B2 (en) * 2003-11-26 2009-01-13 Alcon, Inc. Substituted furo[2,3-g]indazoles for the treatment of glaucoma
US7338972B1 (en) 2003-12-15 2008-03-04 Alcon, Inc. Substituted 1-alkylamino-1H-indazoles for the treatment of glaucoma
TW200520760A (en) 2003-12-15 2005-07-01 Alcon Inc Substituted [1,4] oxazino [2,3-g] indazoles for the treatment of glaucoma
US7129257B1 (en) 2003-12-15 2006-10-31 Alcon, Inc. Pyrazolo[3,4- e]benzoxazoles for the treatment of glaucoma
US7425572B2 (en) 2004-12-08 2008-09-16 Alcon, Inc. Use of dioxindoindazoles and dioxoloindazoles for treating glaucoma
TW200744567A (en) * 2005-09-23 2007-12-16 Alcon Inc Phenylethylamine analogs and their use for treating glaucoma
US20070293475A1 (en) * 2006-06-20 2007-12-20 Alcon Manufacturing Ltd. Aryl and heteroaryl tetrahydrobenzazepine derivatives and their use for treating glaucoma
US20110293549A1 (en) 2009-02-03 2011-12-01 Athena Cosmetics, Inc. Composition, method and kit for enhancing hair

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5011846A (en) * 1988-02-23 1991-04-30 Merrell Dow Pharmaceuticals Inc. Medicament compositions derived from quinolizine and quinolizinone and methods of use thereof
DE1300150T1 (de) * 1988-09-06 2003-09-18 Pharmacia Ab, Stockholm Prostaglandin-Derivate zur Behandlung von Glaukom oder Augenüberdruck
US5578612A (en) * 1990-10-15 1996-11-26 Pfizer Inc. Indole derivatives
EP0593513B1 (en) * 1991-06-21 1998-10-28 Smithkline Beecham Plc Tryptamine analogues, their synthesis and their use as 5-ht1-like receptors or 5-ht2 receptor agonistes
US5352708A (en) * 1992-09-21 1994-10-04 Allergan, Inc. Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US5290781A (en) * 1993-01-05 1994-03-01 Iolab Corporation Ketaneserinol as an agent to reduce intraocular pressure
US5510383A (en) * 1993-08-03 1996-04-23 Alcon Laboratories, Inc. Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension
TW270114B (https=) * 1993-10-22 1996-02-11 Hoffmann La Roche
TW334423B (en) * 1993-10-22 1998-06-21 Hoffmann La Roche Tricyclic 1-aminoethylpyrrole-derivatives
US5538974A (en) * 1994-01-27 1996-07-23 Senju Pharamceutical Co., Ltd. Ophthalmic composition for lowering intraocular pressure
ATE166227T1 (de) * 1994-03-18 1998-06-15 Senju Pharma Co Sarpogrelat enthaltende opthalmologische zubereitungen zur senkung des intraokularen druckes
US5874477A (en) * 1994-08-12 1999-02-23 The University Of Hawaii Method of treatment for malaria utilizing serotonin receptor ligands
TW403738B (en) * 1994-08-12 2000-09-01 Hoffmann La Roche Tricyclic pyrazole derivatives
WO1997043272A2 (en) * 1996-05-14 1997-11-20 Glaxo Group Limited Benzofurans and benzopyrans as chronobiological agents
US5902815A (en) * 1996-09-03 1999-05-11 Washington University Use of 5HT-2A serotonin agonists to prevent adverse effects of NMDA receptor hypofunction
MXPA00010060A (es) * 1998-04-14 2004-04-23 Arena Pharm Inc Receptores de serotonina humana constitutivamente activados, no endogenos y moduladores de molecula pequenos de los mismos.
GB9819033D0 (en) * 1998-09-01 1998-10-28 Cerebrus Ltd Chemical compounds VI
GB9819019D0 (en) * 1998-09-01 1998-10-28 Cerebrus Ltd Chemical compounds II
GB9819035D0 (en) * 1998-09-01 1998-10-28 Cerebrus Res Ltd Chemical compounds VII
CN1269484C (zh) * 1998-09-18 2006-08-16 艾尔科实验室公司 用于治疗青光眼的5-羟色胺激活性激动剂
CA2361516A1 (en) * 1999-01-27 2000-08-03 Jeffrey Thomas Mullaney Aminoalkylbenzofurans as serotonin (5-ht(2c)) agonists
MXPA01012969A (es) * 1999-06-15 2003-10-14 Bristol Myers Squibb Pharma Co Gamma-carbolinas fusionadas de heterociclo sustituido.
AU2001219185A1 (en) * 2000-03-17 2001-10-03 Alcon, Inc. 2-acylaminobenzimidazole derivatives for treating glaucoma
US6806285B1 (en) * 2000-03-17 2004-10-19 Alcon, Inc. 5-Hydroxyl indole derivatives for treating glaucoma
CA2447480A1 (en) * 2001-06-01 2002-12-12 Alcon, Inc. Pyranoindazoles and their use for the treatment of glaucoma
US6884816B2 (en) * 2001-08-31 2005-04-26 Alcon, Inc. Hydroxy substituted fused naphthyl-azoles and fused indeno-azoles and their use for the treatment of glaucoma

Similar Documents

Publication Publication Date Title
JP2019094345A5 (https=)
JP2004516314A5 (https=)
JP2016518437A5 (https=)
JP2009526821A (ja) 注意欠陥多動性障害治療用の新規な医薬組成物
JP2008538741A (ja) 鬱病の治療用及び/又は予防用の医薬組成物
CA2503117A1 (en) Substituted 4-alkoxyoxazol derivatives as ppar agonists
JP2004517099A5 (https=)
JP2008514732A5 (https=)
AU1186795A (en) Inhibition of smooth muscle migration and proliferation with hydroxy carbazole compounds
RU2004104625A (ru) Аналоги простагландинов в качестве агонистов рецептора ep4
JP2006501245A5 (https=)
JP2005504736A5 (https=)
CN1277553A (zh) 血管生成促进剂和血管生成增效剂
RU2006119776A (ru) Производные бензо{b}{1, 4} диоксепина
JP2004534781A5 (https=)
JP2019520344A5 (https=)
JP2005529965A5 (https=)
JP2004502732A5 (https=)
ZA200204964B (en) 2-(1H-Indol-3-yl)-2-oxo-acetamides with antitumor activity.
JP2004525183A5 (https=)
JP2004525184A5 (https=)
JP2006516643A5 (https=)
JP2007503432A5 (https=)
JP2004521913A5 (https=)
JP2010514733A5 (https=)